Genetic polymorphism of murine tissue plasminogen activator associated with antiphospholipid syndrome

Genes and Immunity

Volumn 1, Issue 2, 1999, Pages 130-136

  Shirai, J ^a   Ida, A ^a   Jiang, Y ^a   Sanokawa Akakura, R ^a   Miura, Y ^a,b   Yan, K ^b   Hamano, Y ^a   Hirose, S ^a,c   Shirai, T ^a,c  

^a JUNTENDO UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Anti platelet antibodies; Antiphospholipid syndrome; BXSB mice; Plasmin; Thrombocytopenia; Tissue type plasminogen activator (t PA)

Indexed keywords

MURINAE;

TISSUE PLASMINOGEN ACTIVATOR;

AMINO ACID SEQUENCE; ANIMAL; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; DISEASE MODEL; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MALE; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; THROMBOCYTOPENIA;

AMINO ACID SEQUENCE; ANIMALS; ANTIPHOSPHOLIPID SYNDROME; BASE SEQUENCE; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; MALE; MICE; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; THROMBOCYTOPENIA; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0033224480     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363651     Document Type: Article

References (24)

1. Arnett FC Jr. The genetics of human lupus. In: Wallace DJ, Hahn BH (eds). Dubois' Lupus Erythematosus. Williams & Wilkins: Baltimore, MD, 1997, pp 77-117.
2. Hughes GRV, Harris EN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986; 13: 486-489.
3. Hang LM, Izui S, Dixon FJ. (NZW × BXSB)F1 hybrid: a model of acute lupus and coronary vascular disease with myocardial infarction. J Exp Med 1981; 154: 216-221.
4. Oyaizu N, Yasumizu R, Miyama-Inaba M et al. (NZW × BXSB) F1 mouse: a new animal model of idiopathic thrombocytopenic purpura. J Exp Med 1988; 167: 2017-2022.
5. Hashimoto Y, Kawamura M, Ichikawa K et al. Anticardiolipin antibodies in NZW × BXSB F1 mice: a model of antiphospholipid syndrome. J Immunol 1992; 149: 1063-1068.
6. Goel N, Ortel TL, Bali D et al. Familial antiphospholipid antibody syndrome. Criteria for disease and evidence for autosomal dominant inheritance. Arthritis Rheum 1999; 42: 318-327.
7. Ida A, Hirose S, Hamano Y et al. Multigenic control of lupus-associated antiphospholipid syndrome in a model of (NZW × BXSB) F1 mice. Eur J Immunol 1998; 28: 2694-2703.
8. Bachmann F, Kruithof EKO. Tissue plasminogen activator: chemical and physiological aspects. Semin Thrombo Haemost 1984; 10: 6-17.
9. Collen D. On the regulation and control of fibrinolysis. Thromb Haemost 1980; 43: 77-89.
10. Camiolo SM, Thorsen S, Atrup T. Fibrinogenolysis and fibrinolysis with tissue plasminogen activator, urokinase, streptokinase-activated human globulin, and plasmin. Proc Soc Exp Biol Med 1971; 138: 277-280.
11. Rickles RJ, Darrow AL, Strickland S. Differentiation-responsive elements in the 5′ region of the mouse tissue plasminogen activator gene confer two-stage regulation by retinoic acid and cyclic AMP in teratocarcinoma cells. Mol Cell Biol 1989; 9: 1691-1704.
12. Degen SJF, Rajput B, Reich E. The human tissue plasminogen activator gene. J Biol Chem 1986; 261: 6972-6985.
13. Forejt J, Artzt K, Barlow DP et al. Mouse chromosome 17. Mamm Genome 1994; 5: S238-S258.
14. Degen SJF, Bell SM, Schaefer LA, Elliott RW. Characterization of the cDNA coding for mouse plasminogen and localization of the gene to mouse chromosome 17. Genomics 1990; 8: 49-61.
15. Carmeliet P, Schoonjans L, Kieckens L et al. Physiological consequences of loss plasminogen activator gene function in mice. Nature 1994; 368: 419-424.
16. Saksela O, Rifkin DB. Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol 1988; 4: 93-126.
17. Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest 1991; 88: 1067-1072.
18. Khalil N, Corne S, Whitman C, Yacyshyn II. Plasmin regulates the activation of cell-associated latent TGF-β1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Am J Respir Cell Mol Biol 1996; 15: 252-259.
19. Matsuura E, Inagaki J, Kasahara H et al. A role of proteolytic cleavage of β2-glycoprotein I: reduction of antigenicity in anti-phospholipid syndrome. (Submitted for publication).
20. Peters LL, Barker JE. Novel inheritance of the murine severe combined anemia and thrombocytopenia (scat) phenotype. Cell 1993; 74: 135-142.
21. Kawano H, Abe M, Zhang D et al. Heterozygosity of the major histocompatibility complex controls the autoimmune disease in (NZW × BXSB) F1 mice. Clin Immunol Immunopathol 1992; 65: 308-314.
22. Shirai T. The genetic basis of autoimmunity in murine lupus. Immunol today 1982; 3: 187-194.
23. Rickles RJ, Darrow AL, Strickland S. Molecular cloning of complementary DNA to mouse tissue plasminogen activator mRNA and its expression during F9 teratocarcinoma cell differentiation. J Biol Chem 1988; 263: 1563-1569.
24. Dietrich W, Katz H, Lincoln SE et al. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 1992; 131: 423-447.